Tucson 12/19/2007 2:56:02 AM
News / Health & Wellness

Health freedom presidential candidate Ron Paul raises $6 million with 'Online Boston Tea Party': Newstarget.com

Rep. Ron Paul, the only 2008 presidential candidate who supports honest health freedom reforms and the ending of Big Pharma's monopoly over medical free speech, raised more than $6 million with the record-breaking online "Boston Tea Party" event Jan. 16. Nearly 25,000 of the donors were new donors, indicating that Ron Paul's support base continues to rapidly expand, reaching new people who resonate with the message of genuine freedom for the American people.

 

Registered as a Republican, Ron Paul is actually a Libertarian who strongly disagrees with the current Republican administration. Paul is against the war in Iraq, against the Federal Reserve running the nation's money supply, and against the United States surrendering its sovereignty to outside authorities such as the World Trade Organization.

 

Paul is also the primary congressional sponsor of the "Health Freedom Protection Act" that seeks to end the FDA's censorship of nutritional supplements, granting the American public full access to scientifically accurate information about the benefits of herbs, superfoods and nutritional supplements.

 

The conclusion of this article appears on NewsTarget.com, the independent natural health news source for consumers. This article, along with other related articles and uncensored news on important consumer health topics, can be found at:

 

Health Freedom Candidate Ron Paul Raises $6 Million in Record-Setting Online Boston Tea Party http://www.newstarget.com/022399.html

 

About NewsTarget

Read by over 500,000 unique readers monthly, NewsTarget is a progressive, independent natural health news site that teaches consumers how to improve their health through foods, herbs, exercise and natural therapies. The site also warns consumers about the dangers of processed foods, pharmaceuticals, chemotherapy, environmental toxins and the failure of government regulators like the FDA.